The risk of consequent nephropathy following initial weight loss in diabetic patients treated with sodium glucose cotransporter 2 inhibitors

BACKGROUND: There is a controversy over the association between obesity and the risk of renal events in patients with type 2 diabetes mellitus (T2DM). Furthermore, whether body weight (BW) loss following sodium glucose cotransporter 2 inhibitor (SGLT2i) treatment associated with risk of adverse rena...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yi-Hsin, Chen, Shao-Wei, Chao, Tze-Fan, Kao, Yi-Wei, Huang, Chien-Ying, Chu, Pao-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369784/
https://www.ncbi.nlm.nih.gov/pubmed/34399757
http://dx.doi.org/10.1186/s12933-021-01361-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369784/
https://www.ncbi.nlm.nih.gov/pubmed/34399757
http://dx.doi.org/10.1186/s12933-021-01361-z

Ejemplares similares